Tackling Declining PPA Drugs Reimbursements - hints, tips and strategies

This webinar focused on addressing the pressing issue of declining profits on personally administered items. The reasons behind declining profits can often be complex and elusive, making it challenging for practices to pinpoint the exact causes and take corrective actions.

To help you navigate these challenges, Richard Hole from Ash Lane Consulting brought a wealth of knowledge and experience in helping practices optimize their drug reimbursement processes and maximize their profits.

Key Highlights:

• Understanding the factors contributing to declining PPA drug reimbursements
• Immediate steps practices can take to improve their financial outcomes
• Comprehensive discussion on the FP34 claims process, including:
  • What can be claimed?
  • How FP34 claims result in PCSE Drugs payments
  • Q&A session about any aspect of the FP34 claims process and improving your practice's reimbursement strategy

Recorded on 11 September 2024